Next Article in Journal
Phase II Testing of Sunitinib: The National Cancer Institute of Canada Clinical Trials Group IND Program Trials IND.182–185
Previous Article in Journal
Ifosfamide-Based Combination Chemotherapy in Advanced Soft-Tissue Sarcoma: A Practice Guideline
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 14
Issue 4
10.3747/co.2007.131
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Updated Recommendations from the Canadian National Consensus Meeting on HER2/neu Testing in Breast Cancer

by
W. Hanna
1,*,
F.P. O’Malley
2,*,
P. Barnes
,
R. Berendt
,
L. Gaboury
,
A. Magliocco
,
N. Pettigrew
,
S. Robertson
,
S. Sengupta
,
B. Têtu
and
T. Thomson
1
Anatomic Pathology, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Room E432, Toronto, ON M4N 3M5, Canada
2
Department of Pathology and Lab Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto, ON M5G 1X5, Canada
*
Authors to whom correspondence should be addressed.
Curr. Oncol. 2007, 14(4), 149-153; https://doi.org/10.3747/co.2007.131
Submission received: 2 May 2007 / Revised: 1 June 2007 / Accepted: 4 July 2007 / Published: 1 August 2007

Abstract

Testing for HER2/neu in breast cancer at the time of primary diagnosis is now the standard of care. Accurate and standardized testing methods are of prime importance to ensure the proper classification of the patient’s HER2/neu status. A meeting of pathologists from across Canada was convened to update the Canadian HER2/neu testing guidelines. This National HER2/neu Testing Committee reviewed the recently published American Society of Clinical Oncology/ College of American Pathologists (ASCO/CAP) guidelines for HER2/neu testing in breast cancer. The updated Canadian HER2/neu testing guidelines are based primarily on the ASCO/CAP guidelines, with some modifications. It is anticipated that widespread adoption of these guidelines will further improve the accuracy of HER2/neu testing in Canada.
Keywords: HER2/neu; breast cancer; testing guidelines; immuno-histochemistry; fluorescence in situ hybridization; quality assurance; quality control HER2/neu; breast cancer; testing guidelines; immuno-histochemistry; fluorescence in situ hybridization; quality assurance; quality control

Share and Cite

MDPI and ACS Style

Hanna, W.; O’Malley, F.P.; Barnes, P.; Berendt, R.; Gaboury, L.; Magliocco, A.; Pettigrew, N.; Robertson, S.; Sengupta, S.; Têtu, B.; et al. Updated Recommendations from the Canadian National Consensus Meeting on HER2/neu Testing in Breast Cancer. Curr. Oncol. 2007, 14, 149-153. https://doi.org/10.3747/co.2007.131

AMA Style

Hanna W, O’Malley FP, Barnes P, Berendt R, Gaboury L, Magliocco A, Pettigrew N, Robertson S, Sengupta S, Têtu B, et al. Updated Recommendations from the Canadian National Consensus Meeting on HER2/neu Testing in Breast Cancer. Current Oncology. 2007; 14(4):149-153. https://doi.org/10.3747/co.2007.131

Chicago/Turabian Style

Hanna, W., F.P. O’Malley, P. Barnes, R. Berendt, L. Gaboury, A. Magliocco, N. Pettigrew, S. Robertson, S. Sengupta, B. Têtu, and et al. 2007. "Updated Recommendations from the Canadian National Consensus Meeting on HER2/neu Testing in Breast Cancer" Current Oncology 14, no. 4: 149-153. https://doi.org/10.3747/co.2007.131

APA Style

Hanna, W., O’Malley, F. P., Barnes, P., Berendt, R., Gaboury, L., Magliocco, A., Pettigrew, N., Robertson, S., Sengupta, S., Têtu, B., & Thomson, T. (2007). Updated Recommendations from the Canadian National Consensus Meeting on HER2/neu Testing in Breast Cancer. Current Oncology, 14(4), 149-153. https://doi.org/10.3747/co.2007.131

Article Metrics

Back to TopTop